Journal of Health Sciences and Medicine
Yazarlar: Bekir UÇAN, Taner DEMİRCİ
Konular:Sağlık Bilimleri ve Hizmetleri
DOI:10.32322/jhsm.485584
Anahtar Kelimeler:Acromegaly,Diagnosis,Treatment
Özet: Acromegaly is the clinical syndrome that results from excessive secretion of growth hormone (GH). The most common cause of acromegaly is a GH secreting adenoma of the anterior pituitary. The onset of acromegaly is insidious, and its progression is usually very slow. Nearly all patients with acromegaly have acral osseous and soft tissue overgrowth. The characteristic findings are an enlarged jaw and enlarged, swollen hands and feet. Patients with acromegaly appear to be at increased risk for cadiovascular disase, colon cancer, thyroid cancer and other tumors. Death is generally caused by cardiovascular diseases. Transsphenoidal surgery is the main therapy for patients with an acromegaly. After surgical failure long-acting somatostatin analog, cabergolin or pegvisomant are indicated. If adenoma size increases or GH/IGF-1 hypersecretion persists despite medical therapy, we suggest radiation therapy (RT) or repeat surgery.